Presented by EAS Independent Consultant, Charlotte Peyton
February 17-18, 2021, 1-3pm eastern
As states begin to regulate legalized CBD and hemp, the concern of how Good Manufacturing Practices (GMPs) apply to these unique industries cannot be understated. While regulations vary from state to state the quality systems under which products are grown and manufactured have similarities that can begin to pave the way for putting practices and procedures in place to meet compliance expectations, including those of testing and quality control of in-process materials, finished batches and packaged/labeled products.
The Dietary Supplement Good Manufacturing Practices (GMPs) dictated in 21 CFR 111 have been in place for over a decade and are a respected quality system for the CBD and hemp industries.
Join EAS Independent Consultant and noted expert, Charlotte Peyton for a detailed look at responsibilities and requirements for the CBD and hemp industries as well as understanding how 21 CFR 111 principles can be applied to manufacturing operations including an overview of compliance expectations for testing, quality control and distribution.
The time is right for the CBD and hemp industries to begin assessing manufacturing processes and implementing sound and effective quality systems in order to begin preparation for GMP regulations. Stay ahead of the curve, standardize your product quality and be a leader in your industry.
$149.00 – $199.00
Two or more registrants from the same company – 10% (use GROUP10 discount code at checkout)
* only one discount code may be used
All cancellations after February 10, 2021, will result in a 25% processing fee.
If the minimum number of participants is not met by February 10, 2021, EAS reserves the right to cancel and refund registrations in full.
Terms and Conditions
By submitting this form you will be joining the nearly 20,000 who receive the monthly EASeNews regulatory newsletter. Please note EAS never shares your information and you may unsubscribe at any time.
About the Presenter
EAS Independent Consultant, Charlotte Peyton, supports EAS dietary supplement, pharmaceutical and cannabis clients from startup and growth through manufacturing support. Her expertise includes quality, regulatory and management, method development and method validation for FDA regulated drug, dietary supplement, and bioanalytical samples. She has extensive experience in writing validation protocols, reports and SOPs and assists with implementation of stability programs and report writing for drug and dietary supplement finished products.